Suleymaniye Birth And Women's Health Education And Research Hospital.
Istanbul, 34020, Turkey (Türkiye)
NCT Number: NCT02708628
To investigate the efficacy of prophylactic use of a topical gel containing extract of allium cepae, allantoin and heparin after surgical removal of the primary cesarean scar in the second cesarean section.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Istanbul, 34020, Turkey (Türkiye)
120 patients who are admitted for the second cesarean delivery, not taking prophylactic medication after the first cesarean section, whose scar development and measurements are taken will be included in the study. First caesarean section scars will be removed surgically for all patients. 60 out of 120 patients (treatment group) will use prophylactic topical scar gel 2 times in a day, and remaining 60 patients (control group )won't use. The efficacy of the drug will be evaluated by taking strict measurements of the incision and POSAS (The Patient and Observer Scar Assessment Scale) and Vancouver Scales at 6.12 and 24 weeks.
Steps;
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
prophylactic use of a topical gel containing extract of allium cepae, allantoin and heparin two times in a day after second c-section
Other names: Contractubex
Scar excision in second c-section
Time frame: just prior to second c-section and at 6,12,24 weeks
Time frame: just prior to second c-section and at 6,12,24 weeks
Time frame: just prior to second c-section and at 6,12,24 weeks
Suleymaniye Birth And Women's Health Education And Research Hospital
Other Gov
The Efficacy of Prophylactic Use of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development After Excision of Previous Scar
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07153393
Atrophic Scar, Cicatrix
Naples, Italy
View Trial DetailsNCT04824612
Cicatrix, Collagen Diseases
São Paulo, Brazil
View Trial DetailsNCT04066946
Cicatrix, Fibrosis
Antwerp, Belgium
View Trial DetailsNCT02985151
Carbon Dioxide Laser, Cicatrix
St Louis, Missouri, United States
View Trial Details